MX9801665A - Polimorfos del profarmaco de 6-n-(l-ala-l-ala)-trovafloxacina, procedimiento para su preparacion y uso de los mismos. - Google Patents

Polimorfos del profarmaco de 6-n-(l-ala-l-ala)-trovafloxacina, procedimiento para su preparacion y uso de los mismos.

Info

Publication number
MX9801665A
MX9801665A MX9801665A MX9801665A MX9801665A MX 9801665 A MX9801665 A MX 9801665A MX 9801665 A MX9801665 A MX 9801665A MX 9801665 A MX9801665 A MX 9801665A MX 9801665 A MX9801665 A MX 9801665A
Authority
MX
Mexico
Prior art keywords
ala
pii
trovafloxacin
prodrug
polymorphs
Prior art date
Application number
MX9801665A
Other languages
English (en)
Other versions
MXPA98001665A (es
Inventor
Timothy Norris
James J Mcgarry
Douglas J M Allen
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX9801665A publication Critical patent/MX9801665A/es
Publication of MXPA98001665A publication Critical patent/MXPA98001665A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

Un profármaco de trovafloxacina que tiene la formula (I): que se selecciona entre su polimorfo PII y el monohidrato PII.M y el pseudomorfo PIII.PS del mismo y procedimientos para su preparacion; se describen el polimorfo PII y el monohidrato PII.M y psudomorfo PIII.PS del mismo; la invencion se refiere además al uso de los mismos en la preparacion composiciones farmacéuticas que comprenden los compuestos de la invencion, para el tratamiento de infecciones bacterianas en mamíferos, y las composiciones que los contienen.
MXPA/A/1998/001665A 1995-08-29 1998-02-27 Polimorfos del profarmaco de 6-n-(l-ala-l-ala)-trovafloxacina, procedimiento para su preparacion y uso de los mismos MXPA98001665A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US510995P 1995-08-29 1995-08-29
US005109 1995-08-29
PCT/IB1996/000653 WO1997008191A1 (en) 1995-08-29 1996-07-05 Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin

Publications (2)

Publication Number Publication Date
MX9801665A true MX9801665A (es) 1998-08-30
MXPA98001665A MXPA98001665A (es) 1998-11-12

Family

ID=

Also Published As

Publication number Publication date
KR100274736B1 (ko) 2000-12-15
ES2164892T3 (es) 2002-03-01
HRP960396A2 (en) 1998-04-30
NO309039B1 (no) 2000-12-04
YU48296A (sh) 1998-12-23
RU2151152C1 (ru) 2000-06-20
MA23965A1 (fr) 1997-04-01
WO1997008191A1 (en) 1997-03-06
PT847400E (pt) 2002-03-28
CA2230303A1 (en) 1997-03-06
PL325203A1 (en) 1998-07-06
EP0847400B1 (en) 2001-11-14
CZ55298A3 (cs) 1999-02-17
CA2230303C (en) 2001-07-24
NZ310542A (en) 1999-09-29
AP9600854A0 (en) 1996-10-31
SK283354B6 (sk) 2003-06-03
OA10670A (en) 2000-11-06
DE69617027T2 (de) 2002-03-21
CZ291524B6 (cs) 2003-03-12
IL122652A (en) 2000-01-31
EP0847400A1 (en) 1998-06-17
NO980863D0 (no) 1998-02-27
UA48982C2 (uk) 2002-09-16
HUP9900226A3 (en) 1999-11-29
US6080756A (en) 2000-06-27
AU696414B2 (en) 1998-09-10
AR004507A1 (es) 1998-12-16
DZ2088A1 (fr) 2002-07-22
TR199800340T1 (xx) 1998-06-22
HUP9900226A2 (hu) 1999-05-28
KR19990044231A (ko) 1999-06-25
CO4480740A1 (es) 1997-07-09
TNSN96110A1 (fr) 2005-03-15
JPH11509188A (ja) 1999-08-17
DK0847400T3 (da) 2002-03-25
IL122652A0 (en) 1996-08-16
PL185709B1 (pl) 2003-07-31
SK23798A3 (en) 1999-05-07
AU6135196A (en) 1997-03-19
DE69617027D1 (de) 2001-12-20
CN1193977A (zh) 1998-09-23
NO980863L (no) 1998-02-27
ZA967281B (en) 1998-03-02
GT199600061A (es) 1998-01-31
AP639A (en) 1998-04-14
ATE208790T1 (de) 2001-11-15
BR9610283A (pt) 1999-03-16

Similar Documents

Publication Publication Date Title
LU91145I9 (es)
GR3030342T3 (en) Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase.
WO2002060879A3 (en) Bacterial gyrase inhibitors and uses thereof
RU95106362A (ru) Производные липопептида, способ их получения, содержащая их фармацевтическая композиция и способ ее получения
EP1090908A3 (en) Cyclobutane derivatives as inhibitors of protein farnesyltransferase
PL367682A1 (en) Dolastatin 10 derivatives
IL123002A0 (en) 1-Phenyl-2- phenylacetoxy- ethanone derivatives
IL165715A0 (en) 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
HUT72436A (en) Process for the production of imidazopyridines and pharmaceutical compositions containing them and which are suitable for treating gastro-intestinal diseases
DK0854874T3 (da) Makrocykliske lactonforbindelser og fremgangsmåde til fremstilling af disse
HUP0300534A2 (hu) Tumorellenes ekteinaszcidinszármazékok és ezeket tartalmazó gyógyszerkészítmények
AU6484199A (en) Carbamate and carbazate ketolide antibiotics
YU89402A (sh) 5-hloro-3-(4-metansulfonilfenil)-6'-metil-/2,3'/bipiridinil u čistom kristalnom obliku i postupak sinteze
RU94036745A (ru) Производные галантамина и фармацевтическая композиция
NO974320L (no) Fucopeptider
HUP0004793A2 (hu) Eljárás alatrofloxacin-mezilát tisztítására és alkalmazására, a vegyületet tartalmazó parenterális készítmények
DK1007530T3 (da) 6-O-substituerede erythromycinforbindelser samt fremgangsmåde til fremstilling heraf
DE69715173D1 (en) Bisarylcyclobutenderivate als cyclooxygenasehemmer
HUP9904638A2 (hu) Szubsztituált benzopiránszármazékok alkalmazása gyógyszerkészítmények előállítására
CA2230303A1 (en) Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin
NO20041573L (no) Aralkyl-tetrahydro-pyridiner, deres fremstilling og farmasoytiske preparater inneholdende de samme
WO2003080631A3 (en) Plasma carboxypeptidase b inhibitors
AU6826700A (en) Ceramide analogs, process for their preparation and their use as antitumor agents
WO2002018353A3 (en) Oxazolidinone chemotherapeutic agents
AP2002002494A0 (en) Hygromycin derivatives.